Sector

Cell and Gene therapies are an exciting novel class of pharmaceuticals, and an area where pharma services including CDMOs are likely to play a...

Global pharmaceutical company, Johnson & Johnson (J&J), is investing more than €125m (US$134m) in its Latina manufacturing plant close to Rome, bolstering production capacity...

Denmark-based preclinical CRO, Scantox, together with its majority owner Impilo, has acquired Gentronix, a UK based GLP compliant genetic toxicology CRO. Gentronix is recognized...

Hong Kong-listed global biopharma, Ascentage Pharma, has priced a US IPO on Nasdaq offering of 7,325,000 ADS, at US$17.25 per ADS. Each ADS represents...

Euronext and Nasdaq-listed global healthcare company, Sanofi, and US-based Dren Bio, a private clinical-stage biopharmaceutical company, have entered into a definitive agreement under which...

Alantra, a global alternative asset management, investment banking, and credit portfolio advisory firm, acted as exclusive financial advisor to Perrigo Company on the divestment...

US-headquartered PCI Pharma Services (PCI), a global CDMO focused on innovative biotherapies, has received a strategic investment co-led by Bain Capital and existing lead investor Kohlberg,...

France-based SGD Pharma, a PAI Partners portfolio company providing pharmaceutical glass packaging, has acquired Italy-based Alphial, a producer of tubular vials and ampoules, from...

Queen’s Park Equity (QPE) has supported the MBO of Initiate Consultancy, a UK-based market access and HEOR consultancy services company for clients across the...

InnoDiab Forschung, a specialised clinical research centre, has joined Certainia’s Life Sciences segment, strengthening Certania’s capabilities in diabetes, obesity and related metabolic diseases. “InnoDiab expands...